FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nizatidine Capsules
Status: Currently in Shortage
»Date first posted: 03/27/2020
»Therapeutic Categories: Gastroenterology

Expand all

Glenmark Pharmaceuticals (New 03/27/2020)

Company Contact Information:
201-331-4282

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, 30 count bottle (NDC 68462-0426-30) Unavailable This was a business-related decision to discontinue manufacturing these products.

Link to discontinuance

150 mg, 60 count bottle (NDC 68462-0425-60) Unavailable This was a business-related decision to discontinue manufacturing these products.

Link to discontinuance

Teva Pharmaceuticals (Reverified 09/17/2020)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, 30 count bottle (NDC 0591-3138-30) Supply Interruption Duration of the supply interruption is unknown at this time. Other
150 mg, 60 count bottle (NDC 0591-3137-60) Supply Interruption Duration of the supply interruption is unknown at this time. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English